Literature DB >> 16470357

[Sequelae of hypertenson: kidney disease].

W H Hörl1.   

Abstract

Nephropathy is one of the frequent sequelae of hypertension. Arterial hypertension causes both arterial and capillary changes in the kidneys as well as development of interstitial fibrosis. Systemic or intraglomerular pressure increase leads to albuminuria and proteinuria, which in turn contributes to further damage of the kidneys. Impairment of the kidneys due to hypertension can ultimately result in terminal renal insufficiency necessitating dialysis. Metabolic factors such as hyperlipidemia, hyperuricemia, hyperhomocysteinemia, and insulin resistance can aggravate renal lesions. Effective lowering of blood pressure in conjunction with management of the metabolic risk factors is decisive for prevention of chronic kidney disease, which in turn must be considered a factor involved in exacerbation of the hypertension.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16470357     DOI: 10.1007/s00108-005-1575-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  32 in total

1.  Multifactoral analysis of determinators for renal injury in essential hypertension.

Authors:  L Tylicki; H Puttinger; P Rutkowski; T Nieweglowski; B Rutkowski; W H Hörl
Journal:  J Hum Hypertens       Date:  2006-01       Impact factor: 3.012

2.  Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats.

Authors:  Edna D Lekgabe; Helen Kiriazis; Chongxin Zhao; Qi Xu; Xiao Lei Moore; Yidan Su; Ross A D Bathgate; Xiao-Jun Du; Chrishan S Samuel
Journal:  Hypertension       Date:  2005-06-20       Impact factor: 10.190

Review 3.  Nephroangiosclerosis and hypertension: things are not as simple as you might think.

Authors:  A Meyrier; P Simon
Journal:  Nephrol Dial Transplant       Date:  1996-11       Impact factor: 5.992

4.  Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

Authors: 
Journal:  Lancet       Date:  1997-06-28       Impact factor: 79.321

5.  Albuminuria in normotensive and hypertensive individuals attending offices of general practitioners.

Authors:  D Hörner; D Fliser; H P Klimm; E Ritz
Journal:  J Hypertens       Date:  1996-05       Impact factor: 4.844

6.  Renal injury from angiotensin II-mediated hypertension.

Authors:  R J Johnson; C E Alpers; A Yoshimura; D Lombardi; P Pritzl; J Floege; S M Schwartz
Journal:  Hypertension       Date:  1992-05       Impact factor: 10.190

Review 7.  Multifactorial determination of hypertensive nephroangiosclerosis.

Authors:  Leszek Tylicki; Boleslaw Rutkowski; Walter H Hörl
Journal:  Kidney Blood Press Res       Date:  2002       Impact factor: 2.687

8.  Insulin resistance and risk of chronic kidney disease in nondiabetic US adults.

Authors:  Jing Chen; Paul Muntner; L Lee Hamm; Vivian Fonseca; Vecihi Batuman; Paul K Whelton; Jiang He
Journal:  J Am Soc Nephrol       Date:  2003-02       Impact factor: 10.121

9.  Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene.

Authors:  Ovidiu Baltatu; Cécile Cayla; Radu Iliescu; Dmitrii Andreev; Cynthia Jordan; Michael Bader
Journal:  J Am Soc Nephrol       Date:  2002-11       Impact factor: 10.121

10.  Blood pressure and end-stage renal disease in men.

Authors:  M J Klag; P K Whelton; B L Randall; J D Neaton; F L Brancati; C E Ford; N B Shulman; J Stamler
Journal:  N Engl J Med       Date:  1996-01-04       Impact factor: 91.245

View more
  1 in total

Review 1.  [Kidney and hypertension].

Authors:  I Quack; L C Rump
Journal:  Internist (Berl)       Date:  2009-04       Impact factor: 0.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.